Amalgamated Bank’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.36M Sell
133,275
-947
-0.7% -$43.9K 0.04% 343
2026
Q1
$5.88M Buy
134,222
+3,996
+3% +$182K 0.05% 352
2025
Q4
$5.77M Sell
130,226
-5,080
-4% -$219K 0.04% 359
2025
Q3
$5.71M Buy
135,306
+2,827
+2% +$114K 0.04% 360
2025
Q2
$4.86M Buy
132,479
+3,856
+3% +$143K 0.04% 406
2025
Q1
$4.9M Buy
128,623
+526
+0.4% +$19.6K 0.04% 376
2024
Q4
$4.85M Buy
128,097
+5,696
+5% +$228K 0.04% 397
2024
Q3
$4.98M Sell
122,401
-2,623
-2% -$99.2K 0.04% 390
2024
Q2
$4.28M Sell
125,024
-21,059
-14% -$663K 0.04% 498
2024
Q1
$4.63M Sell
146,083
-17,179
-11% -$522K 0.04% 491
2023
Q4
$5.01M Buy
163,262
+3,767
+2% +$121K 0.04% 476
2023
Q3
$5.29M Buy
159,495
+6,492
+4% +$207K 0.05% 410
2023
Q2
$4.7M Sell
153,003
-8,268
-5% -$239K 0.04% 463
2023
Q1
$4.42M Sell
161,271
-27,799
-15% -$774K 0.04% 504
2022
Q4
$5.29M Buy
189,070
+21,158
+13% +$638K 0.05% 436
2022
Q3
$4.95M Sell
167,912
-1,051
-0.6% -$32.9K 0.05% 393
2022
Q2
$4.76M Buy
168,963
+3,013
+2% +$85.8K 0.04% 441
2022
Q1
$5.17M Sell
165,950
-5,238
-3% -$154K 0.04% 465
2021
Q4
$5.07M Sell
171,188
-1,406
-0.8% -$41.1K 0.04% 515
2021
Q3
$5.17M Sell
172,594
-14,894
-8% -$512K 0.04% 481
2021
Q2
$6.8M Buy
187,488
+158,866
+555% +$5.9M 0.05% 357
2021
Q1
$1.05M Sell
28,622
-1,335
-4% -$49.1K 0.04% 529
2020
Q4
$1.09M Buy
29,957
+91
+0.3% +$3.08K 0.04% 486
2020
Q3
$894K Sell
29,866
-147
-0.5% -$4.59K 0.04% 503
2020
Q2
$892K Sell
30,013
-19,950
-40% -$591K 0.04% 469
2020
Q1
$1.33M Buy
49,963
+309
+0.6% +$11.7K 0.03% 506
2019
Q4
$2.1M Buy
49,654
+5,669
+13% +$240K 0.04% 483
2019
Q3
$1.84M Sell
43,985
-761
-2% -$29.6K 0.04% 472
2019
Q2
$1.64M Buy
44,746
+4,474
+11% +$163K 0.04% 506
2019
Q1
$1.54M Buy
40,272
+816
+2% +$30.3K 0.04% 527
2018
Q4
$1.39M Buy
39,456
+1,189
+3% +$41.2K 0.04% 486
2018
Q3
$1.25M Sell
38,267
-1,706
-4% -$54.3K 0.03% 556
2018
Q2
$1.24M Buy
39,973
+970
+2% +$27.7K 0.03% 641
2018
Q1
$1.05M Sell
39,003
-380
-1% -$10.1K 0.03% 678
2017
Q4
$1.08M Buy
39,383
+2,260
+6% +$65.3K 0.03% 673
2017
Q3
$1.19M Sell
37,123
-835
-2% -$26.8K 0.04% 557
2017
Q2
$1.25M Buy
37,958
+8,442
+29% +$279K 0.04% 510
2017
Q1
$974K Sell
29,516
-1,661
-5% -$53.3K 0.05% 443
2016
Q4
$975K Buy
31,177
+3,364
+12% +$104K 0.04% 489
2016
Q3
$986K Buy
27,813
+423
+2% +$15K 0.06% 368
2016
Q2
$1.01M Buy
27,390
+5,276
+24% +$176K 0.06% 362
2016
Q1
$781K Buy
22,114
+1,862
+9% +$61K 0.08% 307
2015
Q4
$708K Sell
20,252
-1,355
-6% -$46.8K 0.09% 264
2015
Q3
$759K Buy
21,607
+234
+1% +$8.22K 0.08% 283
2015
Q2
$734K Buy
21,373
+13,233
+163% +$486K 0.07% 322
2015
Q1
$330K Buy
8,140
+1,223
+18% +$50.6K 0.04% 637
2014
Q4
$270K Buy
6,917
+89
+1% +$3.37K 0.04% 645
2014
Q3
$233K Buy
6,828
+81
+1% +$2.98K 0.03% 723
2014
Q2
$249K Sell
6,747
-7,561
-53% -$270K 0.04% 700
2014
Q1
$480K Sell
14,308
-91
-0.6% -$2.9K 0.08% 328
2013
Q4
$429K Buy
14,399
+4,227
+42% +$134K 0.07% 377
2013
Q3
$304K Buy
+10,172
New +$310K 0.1% 214

Other funds holding OHI

Amalgamated Bank's OHI Position: Q2 2026 in Review

Amalgamated Bank reduced its Omega Healthcare (OHI) stake by 0.71% in Q2 2026, selling an estimated $43.9K and leaving 133,275 shares worth $6.36M. The position accounts for 0.04% of the portfolio, ranked #343.

Amalgamated Bank first reported a position in OHI in Q3 2013 and has held it in 52 quarters since. The position peaked at $6.8M in Q2 2021. 407 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Amalgamated Bank held 133,275 shares of Omega Healthcare worth $6.36M as of Q2 2026.
  • Amalgamated Bank sold 947 Omega Healthcare shares in Q2 2026, an estimated $43.9K.
  • Omega Healthcare made up 0.04% of Amalgamated Bank's portfolio in Q2 2026, its #343 holding.
  • Amalgamated Bank first reported a position in Omega Healthcare in Q3 2013 and has held it in 52 quarters since.
  • Amalgamated Bank's Omega Healthcare position peaked at $6.8M in Q2 2021.
  • 407 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.